COVID-19 has significantly impacted the healthcare sector across the globe. There has been a rush to get medicines and medical devices (including COVID-19 test kits, face masks, ventilators, vaccines and digital thermometers) to clinical trials and to market.
Never before has there been such demand for urgent and practical therapeutic goods regulatory advice.
This 60 minute webinar, held in conjunction with AusBiotech, with speakers from across the globe, will delve into what the regulators (TGA, FDA and European Medicines Agency) are doing to facilitate the supply of therapeutic goods to market quickly due to COVID-19, including:
• what are the legal, regulatory and ethical issues of rushing medicines and medical devices to market, including human rights and equity of access?
• what is involved with off-label use?
• what are governments in Australia, the USA, the European Union and South America doing to fast track approval therapeutic goods?
Due to the international timezones, we are holding this seminar twice.
We hope you can join us.